Lars Fruergaard Jørgensen

NOVO NORDISK A/S, NOVO NORDISK PHARMACEUTICALS A/S, NOVO NORDISK REGION AAMEO AND LATAM A/S, NOVO NORDISK INVEST 2 A/S, NOVO NORDISK REGION JAPAN & KOREA A/S, NOVO NORDISK REGION EUROPE A/S, NOVO NORDISK GSC HOLDING A/S, Novo Nordisk Invest 4 A/S, Novo Nordisk North America Operations A/S, NOVO NORDISK REGION CHINA A/S and 2 more

NOVO NORDISK REGION AAMEO AND LATAM A/S, Novo Nordisk North America Operations A/S, Novo Nordisk Denmark A/S, NOVO NORDISK PHARMACEUTICALS A/S, NOVO NORDISK REGION EUROPE A/S, NOVO NORDISK A/S, NOVO NORDISK INVEST 2 A/S, Novo Nordisk Invest 4 A/S, NOVO NORDISK REGION JAPAN & KOREA A/S, NOVO NORDISK GSC HOLDING A/S and 1 more

NOVO NORDISK PHARMACEUTICALS A/S, NOVO NORDISK REGION AAMEO AND LATAM A/S, NOVO NORDISK INVEST 2 A/S, NOVO NORDISK REGION JAPAN & KOREA A/S, NOVO NORDISK REGION EUROPE A/S, NOVO NORDISK GSC HOLDING A/S, Novo Nordisk Invest 4 A/S, Novo Nordisk North America Operations A/S, NOVO NORDISK REGION CHINA A/S